Revolutionary COVID-19 Treatment Discovered in a Cancer Drug

Medicine & Technology Jan 27, 2021

A study recently showed that treatment for COVID-19 derived from a rare sea animal and historically used for cancer treatment is more efficient by 27.5 times than the popular COVID-19 drug remdesivir.

Remdesivir Does Not Cut Hospital Days and Mortality on COVID-19 Patients, WHO Study Reveals

Oct 16, 2020

The results from WHO's Solidarity trial revealed that remdesivir has little to no effect on cutting the hospital days and mortality of COVID-19 patients.

COVID 19: Pfizer Teams up With Gilead to Manufacture Remdesivir

Aug 07, 2020

Pharmaceutical giant Pfizer has signed a multi-year deal with Gilead Sciences Inc., to boost the production of its investigational antiviral remdesivir, a potential drug against COVID-19.

Gilead Finally Releases Price for Esteemed Coronavirus Drug Remdesivir; Can People Afford It?

Jun 29, 2020

The price for remdesivir is out, and Gilead Sciences says it could cost up to $2,340 per patient for most wealthy nations. Some patient advocates contend that the price should be less, considering its development and trials received aid from the U.S. government. Click the link above to learn more.

Gilead’s Remdesivir Prevents Lung Damage in Monkeys, Adding to Its Long List of Successful Findings

Jun 09, 2020

Gilead's drug for coronavirus, remdesivir, once again shows its potential after a clinical trial reveals that it prevents lung damage in monkeys. Additionally, the results of the trial showed that the monkeys had minimal damage to their lungs in comparison with the control group.

Next on Gilead's Agenda: Inhaled Remdesivir and Other User-Friendly Versions of the Drug

Jun 03, 2020

Gilead Sciences just finished its phase 3 trials for remdesivir, and the results have been positive. As for the next step, the company seeks to explore making inhaled versions of the drug for early treatment of COVID-19 as well as easier treatment at home.

Gilead's Trials on Remdesivir to End in May; Worries on Access to the Drug Now Arises

May 15, 2020

The trials for Gilead's remdesivir is said to end in May. With the drug only being used for COVID-19 patients under the emergency use authorization, many worry about their access to the drug that has proved to be helpful against the coronavirus. Click the link above to learn more.

Remdesivir First FDA-Approved Drug for COVID-19 Could Cost up to $4,500 Despite Costing Just $9.32 to Manufacture

May 07, 2020

Remdesivir is now finally the first drug to be approved by the US FDA to treat COVID-19. However, controversy has started regarding its price. Experts say that is could cost up to $4,500 despite requiring just $9.32 to make. Click the link to read more.

Remdesivir Vs Coronavirus: Nearly All Patients Discharged in Less Than A Week, Only 2 Died, Phase 3 Trials Showed

Apr 16, 2020

Remdesivir, the drug candidate of Gilead Sciences showed promising results from its two phase three trials. Experts believe the drug would most likely lead to fast approvals by the Food and Drug Administration as long as proven safe and effective.